💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

The hedge fund exec charged with insider trading last week has been found dead

Published 06/21/2016, 09:27 AM
Updated 06/21/2016, 11:49 AM
© REUTERS/Lucas Jackson, Sanjay Valvani, a portfolio manager at Visium.
DJI
-

Sanjay Valvani, a portfolio manager at Visium Asset Management who was charged with insider trading last week, was found dead Monday night.

"We mourn the tragic loss of Sanjay, a devoted father, husband, and friend," Jacob Gottlieb, Visium's founder, said in a statement. "Our thoughts are with his family during this difficult time."

A New York Police Department representative said Valvani was found by his wife and left a suicide note.

Valvani, 44, turned himself in to authorities last week. He was charged with netting about $25 million for an unnamed investment firm using inside information on the pending approval of a generic drug. Valvani had pleaded not guilty.

Visium had placed Valvani on leave earlier this year after it announced that it was under investigation. The hedge fund said on Friday that it would shut down its operations.

Valvani faced numerous charges, according to the complaint:

  • Valvani was accused of committing securities and wire fraud with a former senior Food and Drug Administration official, Gordon Johnston, from about 2005 through 2011.
  • Valvani "unlawfully obtained highly confidential and material nonpublic information from the FDA about the agency's approval of pending generic drug applications," according to the US attorney's statement.
  • Valvani was also charged with passing material nonpublic info to Chris Plaford, a former Visium portfolio manager, who allegedly traded on that info.
  • Johnston and Plaford have pleaded guilty and admitted their participation in the scheme.
  • The complaint said Valvani instructed Johnston, the former FDA official, about the status and approval of a generic drug, and Johnston passed along that info back to Valvani. Valvani was accused of using that info to bet on two pharma companies that were likely to be affected by the inside tip, allegedly netting about $25 million in trading profits. Valvani was also accused of tipping off Plaford on this info.

A representaive for the Department of Justice declined to comment on whether Valvani's death would affect the case.

Dow Jones earlier reported that the death was an apparent suicide.

*An earlier version of this article said that Valvani was found dead Tuesday morning. It has been corrected.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.